How Hims & Hers Reached a $4.3BN Market Cap on $2.3BN of Revenue | Andrew Dudum
Andrew Dudum (guest), Harry Stebbings (host)
In this episode of The Twenty Minute VC, featuring Andrew Dudum and Harry Stebbings, How Hims & Hers Reached a $4.3BN Market Cap on $2.3BN of Revenue | Andrew Dudum explores how Hims scaled fast using grit, AI, brand, disruption strategy Dudum argues public markets are energizing because quarterly accountability forces operational discipline, sharper hiring, and clearer long-term storytelling.
How Hims scaled fast using grit, AI, brand, disruption strategy
Dudum argues public markets are energizing because quarterly accountability forces operational discipline, sharper hiring, and clearer long-term storytelling.
He describes a hiring philosophy centered on “grit” and builder-operators who have navigated real crises, warning against over-indexing on credentialed “big company strategy” hires.
Hims is run like a venture portfolio of clinical category bets, prioritizing being “best in market” (trusted protocols and supply chain) over being first, while avoiding commodity product traps.
AI is being pushed into nearly every function—especially creative production and clinical workflows—to multiply output, standardize care, and improve patient experience rather than simply cut headcount.
The long-term vision is a low-cost or free preventative “front door” (labs, biomarkers, risk scoring) enabled by vertical integration in at-home blood collection and lab processing, alongside continued pressure on pricing and distribution inefficiencies like PBMs.
He frames Hims as a direct disruptor of healthcare distribution toward mobile-first, transparent, consumer-controlled care, which creates friction and public criticism but also drives structural change (e.g., GLP-1 cash-pay price compression).
Key Takeaways
Public markets can be a performance advantage, not just a burden.
Dudum treats the 90-day cadence as “boot camp” that sharpens execution and makes it easier to recruit talent around a visible, validated long-term narrative.
Get the full analysis with uListen AI
Hire people who have proven calm and competence in chaos.
He looks for operators forged by crises (e. ...
Get the full analysis with uListen AI
Avoid the ‘professionalization trap’ as you scale.
Dudum says founders often over-hire credentialed strategists instead of builders; the result is slower execution and weaker ownership versus tactically excellent operators who love to build.
Get the full analysis with uListen AI
Replace yourself every 12 months by hiring smarter-than-you leaders.
He argues the CEO role must continuously move to higher-leverage work, which requires trusting strong leaders while selectively going deep only on the most critical areas.
Get the full analysis with uListen AI
AI’s biggest immediate ROI may be output expansion, not cost cutting.
At Hims, AI accelerates creative iteration for a ~$1B marketing engine (more variations, faster production) and improves clinical workflow standardization and efficiency at high patient volume.
Get the full analysis with uListen AI
Run product expansion like a venture portfolio with clear kill/fund rules.
Hims manages many clinical categories as independent bets—some are starved, some ring-fenced for exploration, some scaled—so the company isn’t dependent on a single trend like GLP-1s.
Get the full analysis with uListen AI
Brand marketing works when it’s consistently repeated, not ‘cool’ one-offs.
He says out-of-home and other brand spend fails when done sporadically; great brands “say the same thing in 20 different ways” until it becomes culturally sticky.
Get the full analysis with uListen AI
Being best-in-market protects trust in sensitive healthcare categories.
Rather than rushing into emerging categories (e. ...
Get the full analysis with uListen AI
Preventative diagnostics can be the strategic loss leader that powers everything else.
He wants near-free biomarker/genetic risk testing through verticalized devices and labs, creating data-driven personalization and long-term retention via a trusted ‘health quarterback’ relationship.
Get the full analysis with uListen AI
True disruption creates enemies—and that may be a signal you’re changing the system.
He links public criticism to Hims applying pressure that helped reshape GLP-1 distribution and pricing, and he targets broader disruption of PBM/insurance complexity toward consumer transparency and control.
Get the full analysis with uListen AI
Notable Quotes
“I might be the only person that believes this, but I think running the company in the public markets is more fun than being private.”
— Andrew Dudum
“I look for mostly people who have been builders and have gone through some shit.”
— Andrew Dudum
“If you can't hire people that are smarter than you, you will fail.”
— Andrew Dudum
“I don't think we actually need to be first ever in market. I wanna be best in market.”
— Andrew Dudum
“What makes great brands great is… they say the same damn thing in 20 different ways every single week.”
— Andrew Dudum
Questions Answered in This Episode
You said Hims is ‘not a weight loss business’—what’s the current revenue mix across your top clinical categories, and what mix do you expect by 2030?
Dudum argues public markets are energizing because quarterly accountability forces operational discipline, sharper hiring, and clearer long-term storytelling.
Get the full analysis with uListen AI
How do you operationalize the internal ‘venture portfolio’—what metrics determine when a category is starved, ring-fenced, or aggressively funded?
He describes a hiring philosophy centered on “grit” and builder-operators who have navigated real crises, warning against over-indexing on credentialed “big company strategy” hires.
Get the full analysis with uListen AI
What specific AI changes would you implement today in patient onboarding, triage, and follow-ups that you were ‘a year too slow’ to deploy?
Hims is run like a venture portfolio of clinical category bets, prioritizing being “best in market” (trusted protocols and supply chain) over being first, while avoiding commodity product traps.
Get the full analysis with uListen AI
You claim Hims helped cut GLP-1 cash-pay prices by ~80% in 18 months—what were the concrete levers (partnerships, regulatory pressure, consumer mobilization) and which mattered most?
AI is being pushed into nearly every function—especially creative production and clinical workflows—to multiply output, standardize care, and improve patient experience rather than simply cut headcount.
Get the full analysis with uListen AI
If being both ‘price king’ and ‘feature king’ is the goal, where do you consciously accept trade-offs (speed, margin, breadth of assortment, clinical complexity)?
The long-term vision is a low-cost or free preventative “front door” (labs, biomarkers, risk scoring) enabled by vertical integration in at-home blood collection and lab processing, alongside continued pressure on pricing and distribution inefficiencies like PBMs.
Get the full analysis with uListen AI
Transcript Preview
One of the things I learned earliest in my career is if you can't hire people that are smarter than you, you will fail. What you gain confidence in with brand marketing over time is that consistency is required.
Now, I am so excited for the show today. We have Andrew Dudum, founder and CEO of Hims. Hims are reinventing healthcare, but wow, been a tough six months. They are down 66%. They've got a market cap of 4.35 billion as of today, but they do over 2.3 billion in revenue. It's nuts. I'm so excited to sit down with Andrew today, where we discuss this and so much more.
When you're disrupting an industry, you have to have a team that is used to being uncomfortable, and used to getting through it, and used to staying calm, and having that resilience. I might be the only person that believes this, but I think running the company in the public markets is more fun than being private.
Ready to go? [upbeat music] Andrew, it's been, like, six, seven years. I, I was, I was young and fresh when, when we last met.
So was I.
[laughs]
So, I was a, I was a lot younger. We looked a lot better back then, but I'd say we're pretty good right now.
I, I... listen, I think life's been pretty kind to both of us. Um, can I start with a super weird one? And you might be like, "Dude, I thought we were buddies." But I, I speak to so many public company CEOs today, and I, I can't find a happy one. Are you [laughs] like, Hims & Hers-
Yeah
... are you happy? Are you really happy?
I'm r- I'm r-
Are you?
You know what? I think, I think... I might be the only person that believes this, but I think running the company in the public markets is more fun than being private.
Why? You get shit on every day, dude. I see it, and I'm like, "Oh, poor Andrew."
No.
And I so remember our dinner with you-
No, I love it
... and your lovely wife, and I'm like, "Oh, I like... He's so nice," [laughs] and I see-
I love it
... the shit on Twitter.
I love it.
You do?
I, I l- I love it for a few reasons. One, um, if you're a highly competitive person, you get to put out high benchmarks every 90 days and see if you can actually deliver on it, and you can build a high performance team to say, "Hey, we put this out, and it's a big stretch. Let's go kick ass and figure it out." When you're private, it's so easy to get, to get cozy. You know, the worst case scenario, if you got some VCs that call you and they're stressed out about something. But in the public markets it's like, it's boot camp. It's, it's like you gotta be... You have to deliver. So I love that from a competitive standpoint. I also love the, the, the ability to hire talent, like, in the public markets because they, they can see the vision, and you're forced to not only talk about where you're gonna go 10 years from now, but if you're gonna actually, like, make steps quarter to quarter to prove it. So as a competitive person, I think it's a lot of fun. Also, when you step back, like, you know, we, we went public really early. We went public after, like, uh, I think 36 months of launching, which was a little bit crazy. Um, when you look at the biggest companies in the world, they went public within a first few years of launching. Google, Facebook, Apple, Amazon, all of them. Like, they didn't stay private for 10, 20 years. Uh, you know, they forced... The founder was forced to figure it out in the public markets, how we're gonna grow, how we're gonna get efficient, and how we're gonna tell a big vision and, and I think that's a lot of fun.
Install uListen to search the full transcript and get AI-powered insights
Get Full TranscriptGet more from every podcast
AI summaries, searchable transcripts, and fact-checking. Free forever.
Add to Chrome